Molecular targeted therapies in hepatocellular carcinoma

Seminars in Oncology

Volumn 39, Issue 4, 2012, Pages 486-492

  Tanaka, Shinji ^a   Arii, Shigeki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANTINEOPLASTIC AGENT; AZD 8055; BARASERTIB; BRIVANIB; CABOZANTINIB; CD135 ANTIGEN; CEDIRANIB; CYC 116; CYC116; ENMD 2076; EVEROLIMUS; FIBROBLAST GROWTH FACTOR; FORETINIB; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; REGORAFENIB; SELUMETINIB; SORAFENIB; STEM CELL FACTOR RECEPTOR; SUNITINIB; TEMSIROLIMUS; TREBANANIB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VATALANIB;

CANCER INVASION; CANCER STEM CELL; CONFERENCE PAPER; HUMAN; LIVER CELL CARCINOMA; METASTASIS; MOLECULARLY TARGETED THERAPY; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANGIOGENESIS INHIBITORS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84864434569     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.05.005     Document Type: Conference Paper

References (45)

1. S. Arii, Y. Yamaoka, S. Futagawa Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan The Liver Cancer Study Group of Japan Hepatology 32 2000 1224 1229
2. I.B. Weinstein Cancer Addiction to oncogenes - the Achilles heal of cancer Science 297 2002 63 64
3. S. Tanaka, S. Arii Molecularly targeted therapy for hepatocellular carcinoma Cancer Sci 100 2009 1 8
4. A. Villanueva, J.M. Llovet Targeted therapies for hepatocellular carcinoma Gastroenterology 140 2011 1410 1426
5. S. Tanaka, S. Arii Current status of perspective of antiangiogenic therapy for cancer; hepatocellular carcinoma Int J Clin Oncol 11 2006 82 89
6. P. Carmeliet, F. De Smet, S. Loges, M. Mazzone Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way Nat Rev Clin Oncol 6 2009 315 326
7. M. Mise, S. Arii, H. Higashituji Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor Hepatology 23 1996 455 464
8. J. Andrae, R. Gallini, C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes Dev 22 2008 1276 1312
9. F. Kuhnert, B.Y. Tam, B. Sennino Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis Proc Natl Acad Sci USA 105 2008 10185 10190
10. J.M. Llovet, S. Ricci, V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
11. J. Bruix, M. Sherman American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
12. S. Faivre, E. Raymond, E. Boucher Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study Lancet Oncol 10 2009 794 800
13. S. Tanaka, M. Mori, Y. Sakamoto, M. Makuuchi, K. Sugimachi, J.R. Wands Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma J Clin Invest 103 1999 341 345
14. S. Tanaka, K. Sugimachi, Yi Yamashita, T. Ohga, K. Shirabe, M. Shimada, J.R. Wands, K. Sugimachi Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma Hepatology 35 2002 86-17
15. T. Etoh, H. Inoue, S. Tanaka, G.F. Bernard, S. Kitano, M. Mori Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases Cancer Res 61 2001 2145 2153
16. S. Tanaka, J.R. Wands, S. Arii Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesis J Hepatol 44 2006 233 235
17. B.Y. Karlan, A.M. Oza, G.E. Richardson Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer J Clin Oncol 30 2012 362 371
18. Mross K, Frost A, Steinbild S, et al. A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic and stromal kinases, in patients with advanced solid tumors. Clin Cancer Res. In press.
19. S. Tanaka, K. Sugimachi, S. Maehara Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma Surgery 131 2002 S142 S147
20. P.A. Farazi, R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674 687
21. S. Tanaka, S. Arii Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science Int J Clin Oncol 15 2010 235 241
22. S. Tanaka, S. Arii, M. Yasen Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy Br J Surg 95 2008 611 619
23. N. Keen, S. Taylor Aurora-kinase inhibitors as anticancer agents Nat Rev Cancer 4 2004 927 936
24. A. Aihara, S. Tanaka, M. Yasen The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma J Hepatol 52 2010 63 71
25. S. Loges, M. Mazzone, P. Hohensinner, P. Carmeliet Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited Cancer Cell 15 2009 167 170
26. B. Keith, M.C. Simon Hypoxia-inducible factors, stem cells, and cancer Cell 129 2007 465 472
27. A. Mohyeldin, T. Garzón-Muvdi, A. Quiñones-Hinojosa Oxygen in stem cell biology: a critical component of the stem cell niche Cell Stem Cell 7 2010 150 161
28. F. Arai, T. Suda Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche Ann N Y Acad Sci 1106 2007 41 53
29. H. Iwasaki, T. Suda Cancer stem cells and their niche Cancer Sci 100 2009 1166 1172
30. C. Calabrese, H. Poppleton, M. Kocak A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
31. P. Cammareri, A. Scopelliti, M. Todaro Aurora-A is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells Cancer Res 70 2010 4655 4665
32. 2 regulates stem cells through Wnt/β-catenin signalling Nat Cell Biol 12 2010 1007 1013
33. S. Tanaka, T. Akiyoshi, M. Mori, J.R. Wands, K. Sugimachi A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals Proc Natl Acad Sci U S A 95 1998 10164 10169
34. P. Merle, S. de la Monte, M. Kim Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma Gastroenterology 127 2004 1110 1122
35. S. Tanaka, K. Sugimachi, T. Kameyama Human WISP1v, a member of CCN family, is associated with invasive cholangiocarcinoma Hepatology 37 2003 1122 1129
36. A. Murakata, S. Tanaka, K. Mogushi Gene expression signature of the gross morphology in hepatocellular carcinoma Ann Surg 253 2011 94 100
37. S.M. Huang, Y.M. Mishina, S. Liu Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 461 2009 614 620
38. C.A. Thorne, A.J. Hanson, J. Schneider Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α Nat Chem Biol 6 2010 829 836
39. N. Haraguchi, H. Ishii, K. Mimori CD13 is a therapeutic target in human liver cancer stem cells J Clin Invest 120 2010 3326 3339
40. S. Tanaka, K. Mogushi, M. Yasen Oxidative stress pathways in non-cancerous human liver tissue to predict hepatocellular carcinoma recurrence; a prospective multi-center study Hepatology 54 2011 1273 1281
41. E. Vlashi, K. Kim, C. Lagadec In vivo imaging, tracking, and targeting of cancer stem cells J Natl Cancer Inst 101 2009 350 359
42. T. Dobzhansky Genetics of natural populations XIII. Recombination and variability in populations of Drosophila pseudoobscura Genetics 31 1946 269 290
43. W.G. Kaelin Jr The concept of synthetic lethality in the context of anticancer therapy Nat Rev Cancer 5 2005 689 698
44. J.D. Iglehart, D.P. Silver Synthetic lethality-a new direction in cancer-drug development N Engl J Med 361 2009 189 191
45. Adikrisna R, Tanaka S, Muramatsu S, et al. Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology. In press.